Insider filing · ANTX

Braden Michael Leonard sold $2.9M of AN2 Therapeutics (ANTX)

Executed May 28 2025, disclosed May 30 2025, 2 days later.

Returns are measured on stock purchases only.

BL Braden Michael Leonard 10% owner profile →

Braden Michael Leonard (10% owner) filed 4 Form 4 reports in the trailing twelve months (1 purchase, 3 sales), most often in ADVM. Across 1 priced purchase filing, the average 21-session return was +36.7% from execution and +1.5% from disclosure (delay-adjusted; derived). The largest single filing was $2.4M of ADVM (574,886 sh across 3 lots, as filed), executed Dec 1 2025.

ANTX AN2 Therapeutics, Inc. ANTX · Healthcare · 3 filings in 24 months ticker →

Healthcare · AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→